Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure

Journal of the American College of Cardiology

Volumn 29, Issue 6, 1997, Pages 1214-1220

  Nishigaki, Kazuhiko ^a   Minatoguchi, Shinya ^a   Seishima, Mitsuru ^a   Asano, Kiyoji ^a   Noda, Toshiyuki ^a   Yasuda, Norio ^a   Sano, Hirotake ^a   Kumada, Hirokazu ^a   Takemura, Masao ^a   Noma, Akio ^a   Tanaka, Tsutomu ^b   Watanabe, Sachiro ^c   Fujiwara, Hisayoshi ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gifu Municipal Hospital   (Japan)

^c GIFU PREFECTURAL GIFU HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ADULT; AGED; APOPTOSIS; ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

AGED; APOPTOSIS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; INTERLEUKIN-6; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0030970922     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00055-7     Document Type: Article

References (37)

1. Kerr JFR. Shrinkage necrosis a distinct mode of cellular death . J Pathol. 105:1971;13-21.
2. Kerr JFR, Wyllie AH, Currie AR. Apoptosis a basic biological phenomenon with wide ranging implications in tissue kinetics . Br J Cancer. 26:1972;239-257.
3. Arends MJ, Morris RG, Wyllie AH. Apoptosis the role of the endonuclease . Am J Pathol. 136:1990;593-608.
4. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol. 132:1984;38-42.
5. Searle J, Kerr JFR, Bishop CJ. Necrosis and apoptosis distinct modes of cell death with fundamentally different significance . Pathol Annu. 17:1982;229-259.
6. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis association with condensed chromatin morphology and dependence on macromolecular synthesis . J Pathol. 142:1984;67-77.
7. Walker NI, Harmon BV, Gobe GC, Kerr JF. Patterns of cell death [review]. Methods Achiev Exp Pathol. 13:1988;18-54.
8. James TN. Congenital disorders of cardiac rhythm and conduction [review]. J Cardiovasc Electrophysiol. 4:1993;702-718.
9. Tanaka M, Ito H, Adachi S, et al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultured neonatal rat cardiomyocytes. Circ Res. 75:1994;426-433.
10. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1621-1628.
11. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium of dogs with chronic heart failure. Am J Pathol. 148:1996;141-149.
12. Misao J, Hayakawa Y, Ohno M, Kato S, Fujiwara T, Fujiwara H. The expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation. 94:1996;1506-1512.
13. Stefanelli C, Stanic I, Bonavita F, et al. Oxygen tension influences DNA fragmentation and cell death in glucocorticoid-treated thymocytes. Biophys Res Comm. 212:1995;300-306.
14. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 323:1990;236-241.
15. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in cachectic patients with severe chronic heart failure. Br Heart J. 66:1991;356-358.
16. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlation of increased serum tumor necrosis factor in patients with congestive heart failure relation to nitric oxide-dependent vasodilation in the forearm circulation . Circulation. 90:1994;12-16.
17. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 92:1995;1479-1486.
18. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med. 169:1989;1747-1756.
19. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 66:1991;233-243.
20. Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins activation, costimulation, and death . Cell. 76:1994;959-962.
21. Krammer PH, Behrmann I, Daniel P, Dhein J, Debatin KM. Regulation of apoptosis in the immune system [review]. Curr Opin Immunol. 6:1994;279-289.
22. Nagata S, Golstein P. The Fas death factor [review]. Science. 267:1995;1449-1456.
23. Cheng J, Zhou T, Liu C, et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. Science. 263:1994;1759-1762.
24. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood. 85:1995;1562-1569.
25. Gruss HJ, Dower S. Tumor necrosis factor ligand superfamily involvement in the pathology of malignant lymphoma . Blood. 85:1995;3378-3404.
26. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell. 75:1993;1169-1178.
27. Kayagaki N, Kawasaki A, Ebata T, et al. Metalloproteinase-mediated release of human Fas ligand. J Exp Med. 182:1995;1777-1783.
28. Tanaka M, Suda T, Takahashi T, Nagata S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14:1995;1129-1135.
29. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligand in cells of T cell lineage. J Immunol. 154:1995;3806-3813.
30. Watanabe-Fukunaga R, Brannan CI, Itoh N, et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol. 148:1992;1274-1279.
31. Tanaka M, Suda T, Haze K, et al. Fas ligand in human serum. Nature Med. 2:1996;317-322.
32. Seishima M, Takemura M, Saito K, et al. Highly sensitive enzyme-linked immunosorbent assay for soluble Fas in serum increased soluble Fas in the elderly . Clin Chem. 42:1996;1911-1914.
33. Damas P, Reuter A, Gysen P, Demonty J, Lamy M, Franchimont P. Tumor necrosis factor and interleukin 1 serum levels during severe sepsis in humans. Crit Care Med. 17:1989;975-978.
34. Yamagishi Y, Hidaka Y, Sasaki K, Nihei K, Itoh Y, Kawai T. Determination of serum interleukin-6 concentration by an enzyme-linked immunosorbent assay in patients with paraproteinemia. Jpn J Clin Pathol. 40:1992;303-310.
35. Narula J, Haider N, Virmani R, et al. Apoptosis in myocytes in end-stage heart failure. N Engl J Med. 335:1996;1182-1189.
36. Powell CB, Herzog TJ, Scott JH, Collins JL. Evidence for a protein synthesis-dependent and -independent TNF alpha cytolytic mechanism. Gynecol Oncol. 58:1995;327-335.
37. Wada N, Matsumura M, Ohba Y, Kobayashi N, Takizawa T, Nakanishi Y. Transcription stimulation of the Fas-encoding gene by nuclear factor for interleukin-6 expression upon influenza virus infection. J Biol Chem. 270:1995;18007-18012.